Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study to Investigate the Effect of Testosterone Treatment on Paraoxonase Level in Male Patients With Hypogonadotrophic Hypogonadism

NCT01107067 is registered in ClinicalTrials.gov with Gulhane School of Medicine as lead sponsor.

NCT NCT01107067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01107067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study to Investigate the Effect of Testosterone Treatment on Paraoxonase Level in Male Patients With Hypogonadotrophic Hypogonadism
Lead sponsor
Gulhane School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2008
Completion date
December 31, 2009
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism